IL138478A0 - Paroxetine compositions - Google Patents

Paroxetine compositions

Info

Publication number
IL138478A0
IL138478A0 IL13847899A IL13847899A IL138478A0 IL 138478 A0 IL138478 A0 IL 138478A0 IL 13847899 A IL13847899 A IL 13847899A IL 13847899 A IL13847899 A IL 13847899A IL 138478 A0 IL138478 A0 IL 138478A0
Authority
IL
Israel
Prior art keywords
paroxetine compositions
paroxetine
compositions
Prior art date
Application number
IL13847899A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL138478A0 publication Critical patent/IL138478A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13847899A 1998-03-24 1999-03-24 Paroxetine compositions IL138478A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (1)

Publication Number Publication Date
IL138478A0 true IL138478A0 (en) 2001-10-31

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13847899A IL138478A0 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Country Status (20)

Country Link
EP (1) EP1063993A1 (xx)
JP (1) JP2002507569A (xx)
CN (1) CN1125639C (xx)
AP (1) AP2000001914A0 (xx)
AU (1) AU754765B2 (xx)
BG (1) BG104865A (xx)
BR (1) BR9908991A (xx)
CA (1) CA2324612A1 (xx)
EA (1) EA003393B1 (xx)
GB (1) GB9806312D0 (xx)
HU (1) HUP0101326A3 (xx)
ID (1) ID26485A (xx)
IL (1) IL138478A0 (xx)
NO (1) NO313404B1 (xx)
NZ (1) NZ506893A (xx)
PL (1) PL343095A1 (xx)
SK (1) SK14102000A3 (xx)
TR (1) TR200002750T2 (xx)
WO (1) WO1999048499A1 (xx)
ZA (1) ZA200005697B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
EP1643975A2 (en) * 2003-07-02 2006-04-12 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
AU754765B2 (en) 2002-11-21
EP1063993A1 (en) 2001-01-03
NO313404B1 (no) 2002-09-30
CA2324612A1 (en) 1999-09-30
AU3045199A (en) 1999-10-18
BG104865A (en) 2001-05-31
TR200002750T2 (tr) 2000-12-21
ID26485A (id) 2001-01-11
CN1125639C (zh) 2003-10-29
WO1999048499A1 (en) 1999-09-30
NO20004740L (no) 2000-10-03
HUP0101326A2 (hu) 2002-05-29
JP2002507569A (ja) 2002-03-12
SK14102000A3 (sk) 2001-03-12
PL343095A1 (en) 2001-07-30
BR9908991A (pt) 2000-12-12
EA200000977A1 (ru) 2001-02-26
NZ506893A (en) 2003-06-30
AP2000001914A0 (en) 2000-09-30
CN1294512A (zh) 2001-05-09
HUP0101326A3 (en) 2002-06-28
EA003393B1 (ru) 2003-04-24
ZA200005697B (en) 2001-10-02
GB9806312D0 (en) 1998-05-20
NO20004740D0 (no) 2000-09-22

Similar Documents

Publication Publication Date Title
AP2000001874A0 (en) Cellecoxib compositions
GB9917982D0 (en) Compositions
GB9811377D0 (en) Compositions
GB9924268D0 (en) Compositions
EP0994183A4 (en) FUNCTIONAL COMPOSITIONS
GB9828861D0 (en) Compositions
IL139733A0 (en) Novel compositions
GB9904049D0 (en) Rapidly-soluble compositions
PL343095A1 (en) Paroxetine compositions
GB2339693B (en) Anti-mollusc compositions
GB9805782D0 (en) Compositions
GB9827291D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9806810D0 (en) Compositions
GB9812818D0 (en) Dentfrice compositions
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9816050D0 (en) Compositions
GB9827690D0 (en) Compositions
GB9818278D0 (en) Compositions
AU2003200534A1 (en) Paroxetine compositions
GB9808294D0 (en) Compositions
GB9810375D0 (en) Compositions
GB9824922D0 (en) Odour-neutralising compositions
GB9824924D0 (en) Odour-neutralising compositions